antibacterial peptide Search Results


93
Cusabio brand commercial kits
Brand Commercial Kits, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/Human+Antibacterial+Peptide+LL-37+ELISA+Kit/10__1186_slash_s12301___022___00330___6-55-17-16
Average 93 stars, based on 1 article reviews
brand commercial kits - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Rockland Immunochemicals ll 37
Ll 37, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/LL-37/pmc12323582-37-1-2
Average 94 stars, based on 1 article reviews
ll 37 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Shanghai Korain Biotech Co Ltd human ll37
The SHED-IL10 ( A ) and <t>SHED-LL37</t> ( B ) concentration on the basic condition.
Human Ll37, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/Human+Cathelicidin+Antimicrobial+Peptide/pmc10959608-32-13-18
Average 94 stars, based on 1 article reviews
human ll37 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
NCIMB Ltd cationic antibacterial peptide (cap)
The SHED-IL10 ( A ) and <t>SHED-LL37</t> ( B ) concentration on the basic condition.
Cationic Antibacterial Peptide (Cap), supplied by NCIMB Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/cationic+antibacterial+peptide++cap+/pm24138125-4-3-17
Average 90 stars, based on 1 article reviews
cationic antibacterial peptide (cap) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
IntraBiotics Pharmaceuticals antibacterial peptides
The SHED-IL10 ( A ) and <t>SHED-LL37</t> ( B ) concentration on the basic condition.
Antibacterial Peptides, supplied by IntraBiotics Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/antibacterial+peptides/pm16375700-74-1-16
Average 90 stars, based on 1 article reviews
antibacterial peptides - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Arrevus Inc antibacterial peptides and combinations for co-therapy
Final selection of antimicrobial peptide patents that test against polymyxin-resistant K. pneumoniae
Antibacterial Peptides And Combinations For Co Therapy, supplied by Arrevus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/antibacterial+peptides+and+combinations+for+co+therapy/pmc09889241-3-6-16
Average 90 stars, based on 1 article reviews
antibacterial peptides and combinations for co-therapy - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
SCAPS GmbH selective cationic antibacterial peptides
Two physicochemical properties (Mean Charge, MC, Mean Hydrophobicity, MH) known to differentiate structured from non-structured proteins were applied to <t>antibacterial</t> peptides. The figure shows the paired values of a set of structured antibacterial peptides (empty squares) and unstructured antibacterial peptides (filled circles). See supplementary for further information about the peptide sequences used for this study.
Selective Cationic Antibacterial Peptides, supplied by SCAPS GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/selective+cationic+antibacterial+peptides/pmc03125173-13-7-10
Average 90 stars, based on 1 article reviews
selective cationic antibacterial peptides - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Innovagen AB antibacterial peptides lactoferricin (fqwqrnmrkvr)
Two physicochemical properties (Mean Charge, MC, Mean Hydrophobicity, MH) known to differentiate structured from non-structured proteins were applied to <t>antibacterial</t> peptides. The figure shows the paired values of a set of structured antibacterial peptides (empty squares) and unstructured antibacterial peptides (filled circles). See supplementary for further information about the peptide sequences used for this study.
Antibacterial Peptides Lactoferricin (Fqwqrnmrkvr), supplied by Innovagen AB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/antibacterial+peptides+lactoferricin++fqwqrnmrkvr+/pm12850204-85-1-13
Average 90 stars, based on 1 article reviews
antibacterial peptides lactoferricin (fqwqrnmrkvr) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Arrevus Inc antibacterial peptide monomers and combinations for co-therapy
Final selection of antimicrobial peptide patents that test against polymyxin-resistant K. pneumoniae
Antibacterial Peptide Monomers And Combinations For Co Therapy, supplied by Arrevus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/antibacterial+peptide+monomers+and+combinations+for+co+therapy/pmc09889241-2-9-19
Average 90 stars, based on 1 article reviews
antibacterial peptide monomers and combinations for co-therapy - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Gallus BioPharmaceuticals antibacterial peptide derived from acid extract of chicken (gallus gallus) blood
Final selection of antimicrobial peptide patents that test against polymyxin-resistant K. pneumoniae
Antibacterial Peptide Derived From Acid Extract Of Chicken (Gallus Gallus) Blood, supplied by Gallus BioPharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/antibacterial+peptide+derived+from+acid+extract+of+chicken++gallus+gallus++blood/pm28712131-20-12-10
Average 90 stars, based on 1 article reviews
antibacterial peptide derived from acid extract of chicken (gallus gallus) blood - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
GL Biochem antibacterial peptides yi12
Physicochemical properties of <t> YI12 </t> and FK13. # The isoelectric points (pI) of peptides were predicted by ExPASy ( https://web.expasy.org/protparam/ ), accessed on 20 July 2024.
Antibacterial Peptides Yi12, supplied by GL Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/antibacterial+peptides+yi12/pmc11435022-155-1-12
Average 90 stars, based on 1 article reviews
antibacterial peptides yi12 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics antibacterial peptide-modified silk fibroin
Physicochemical properties of <t> YI12 </t> and FK13. # The isoelectric points (pI) of peptides were predicted by ExPASy ( https://web.expasy.org/protparam/ ), accessed on 20 July 2024.
Antibacterial Peptide Modified Silk Fibroin, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibacterial+peptide/antibacterial+peptide+modified+silk+fibroin/pm35829709-462-35-26
Average 90 stars, based on 1 article reviews
antibacterial peptide-modified silk fibroin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


The SHED-IL10 ( A ) and SHED-LL37 ( B ) concentration on the basic condition.

Journal: European Journal of Dentistry

Article Title: The EGCG and α-Mangosteen Stimulate SHED-IL10 and SHED-LL37 Metabolite Concentration

doi: 10.1055/s-0043-1761460

Figure Lengend Snippet: The SHED-IL10 ( A ) and SHED-LL37 ( B ) concentration on the basic condition.

Article Snippet: The antibody used was human IL-10 (human IL-10, BT Laboratory, Shanghai, China) and human LL37 (human LL317, IL-10, BT Laboratory, Shanghai, China).

Techniques: Concentration Assay

The SHED-IL10 ( A – C ) and SHED-LL37 ( E – F ) concentrations by two different epigallocatechin gallate (EGCG) concentrations and α-mangosteen. *** p < 0.001; **** p < 0.0001.

Journal: European Journal of Dentistry

Article Title: The EGCG and α-Mangosteen Stimulate SHED-IL10 and SHED-LL37 Metabolite Concentration

doi: 10.1055/s-0043-1761460

Figure Lengend Snippet: The SHED-IL10 ( A – C ) and SHED-LL37 ( E – F ) concentrations by two different epigallocatechin gallate (EGCG) concentrations and α-mangosteen. *** p < 0.001; **** p < 0.0001.

Article Snippet: The antibody used was human IL-10 (human IL-10, BT Laboratory, Shanghai, China) and human LL37 (human LL317, IL-10, BT Laboratory, Shanghai, China).

Techniques:

Final selection of antimicrobial peptide patents that test against polymyxin-resistant K. pneumoniae

Journal: World Journal of Microbiology & Biotechnology

Article Title: Antimicrobial peptides against polymyxin-resistant Klebsiella pneumoniae : a patent review

doi: 10.1007/s11274-023-03530-6

Figure Lengend Snippet: Final selection of antimicrobial peptide patents that test against polymyxin-resistant K. pneumoniae

Article Snippet: US2020323950A1/ Abandoned , Antibacterial peptides and combinations for co-therapy (Kraus and Otvos ) , US/2020 , ARREVUS INC [US] , K. pneumoniae (polymyxin-resistant) , A61K38/12; A61K38/16; A61K45/06; A61P31/04.

Techniques: Selection, Mutagenesis

Two physicochemical properties (Mean Charge, MC, Mean Hydrophobicity, MH) known to differentiate structured from non-structured proteins were applied to antibacterial peptides. The figure shows the paired values of a set of structured antibacterial peptides (empty squares) and unstructured antibacterial peptides (filled circles). See supplementary for further information about the peptide sequences used for this study.

Journal: PLoS ONE

Article Title: An FPGA Implementation to Detect Selective Cationic Antibacterial Peptides

doi: 10.1371/journal.pone.0021399

Figure Lengend Snippet: Two physicochemical properties (Mean Charge, MC, Mean Hydrophobicity, MH) known to differentiate structured from non-structured proteins were applied to antibacterial peptides. The figure shows the paired values of a set of structured antibacterial peptides (empty squares) and unstructured antibacterial peptides (filled circles). See supplementary for further information about the peptide sequences used for this study.

Article Snippet: One example is the identification of selective cationic antibacterial peptides (SCAPs), which may be used in the treatment of different diseases.

Techniques:

Final selection of antimicrobial peptide patents that test against polymyxin-resistant K. pneumoniae

Journal: World Journal of Microbiology & Biotechnology

Article Title: Antimicrobial peptides against polymyxin-resistant Klebsiella pneumoniae : a patent review

doi: 10.1007/s11274-023-03530-6

Figure Lengend Snippet: Final selection of antimicrobial peptide patents that test against polymyxin-resistant K. pneumoniae

Article Snippet: WO2020014642A2 WO2020014642A3/ Application filed , Antibacterial peptide monomers and combinations for co-therapy (Kraus and Otvos ) , WO/2020 , ARREVUS INC [US] , K. pneumoniae (polymyxin-resistant) , A61K39/02; A61K31/40; A61K31/56; A61K31/58; A61K31/675; A61K38/04; A61K38/10.

Techniques: Selection, Mutagenesis

Physicochemical properties of  YI12  and FK13. # The isoelectric points (pI) of peptides were predicted by ExPASy ( https://web.expasy.org/protparam/ ), accessed on 20 July 2024.

Journal: Pathogens

Article Title: Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria

doi: 10.3390/pathogens13090797

Figure Lengend Snippet: Physicochemical properties of YI12 and FK13. # The isoelectric points (pI) of peptides were predicted by ExPASy ( https://web.expasy.org/protparam/ ), accessed on 20 July 2024.

Article Snippet: The antibacterial peptides YI12 and FK13 used in the experiment came from GL Biochem (Shanghai, China) and were both synthesized by peptide solid-phase synthesis (SPPS).

Techniques: Sequencing

Characterization of YI12 and FK13 peptides. ( A ) Chemical structures of two AMPs. ( B ) Helical wheel projections of YI12 and FK13. Hydrophilic residues—circle shape, hydrophobic residues—diamond shape, potentially positively charged residues—pentagonal shape, potentially negatively charged residues—triangle shape (none). Hydrophobicity is color-coded: the most hydrophobic residues are green, and the amount of green decreases with hydrophobicity. Hydrophilic residues are coded in red, and the amount of red decreases with hydrophilicity. The residues that may be charged are light blue.

Journal: Pathogens

Article Title: Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria

doi: 10.3390/pathogens13090797

Figure Lengend Snippet: Characterization of YI12 and FK13 peptides. ( A ) Chemical structures of two AMPs. ( B ) Helical wheel projections of YI12 and FK13. Hydrophilic residues—circle shape, hydrophobic residues—diamond shape, potentially positively charged residues—pentagonal shape, potentially negatively charged residues—triangle shape (none). Hydrophobicity is color-coded: the most hydrophobic residues are green, and the amount of green decreases with hydrophobicity. Hydrophilic residues are coded in red, and the amount of red decreases with hydrophilicity. The residues that may be charged are light blue.

Article Snippet: The antibacterial peptides YI12 and FK13 used in the experiment came from GL Biochem (Shanghai, China) and were both synthesized by peptide solid-phase synthesis (SPPS).

Techniques:

 Antibacterial  spectrum of  YI12  and FK13 (MIC, μg/mL). MRSA, methicillin-resistant Staphylococcus aureus . G + , Gram-positive bacteria; G − , Gram-negative bacteria.

Journal: Pathogens

Article Title: Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria

doi: 10.3390/pathogens13090797

Figure Lengend Snippet: Antibacterial spectrum of YI12 and FK13 (MIC, μg/mL). MRSA, methicillin-resistant Staphylococcus aureus . G + , Gram-positive bacteria; G − , Gram-negative bacteria.

Article Snippet: The antibacterial peptides YI12 and FK13 used in the experiment came from GL Biochem (Shanghai, China) and were both synthesized by peptide solid-phase synthesis (SPPS).

Techniques: Bacteria

The growth patterns and time-killing curves of the two MDR bacteria exposed to YI12 and FK13, respectively. ( A – D ) Growth patterns of MRSA T144 and E. coli B2 under YI12 and FK13. ( E , F ) Time-dependent killing curves of MRSA T144 and E. coli B2 by FK13. Bacteria isolates were grown to stationary phase and mixed with 0-, 1-, 5-, and 10-fold MIC of FK13. Data are representative of three independent experiments and shown as mean ± SEM. PBS, phosphate-buffered saline.

Journal: Pathogens

Article Title: Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria

doi: 10.3390/pathogens13090797

Figure Lengend Snippet: The growth patterns and time-killing curves of the two MDR bacteria exposed to YI12 and FK13, respectively. ( A – D ) Growth patterns of MRSA T144 and E. coli B2 under YI12 and FK13. ( E , F ) Time-dependent killing curves of MRSA T144 and E. coli B2 by FK13. Bacteria isolates were grown to stationary phase and mixed with 0-, 1-, 5-, and 10-fold MIC of FK13. Data are representative of three independent experiments and shown as mean ± SEM. PBS, phosphate-buffered saline.

Article Snippet: The antibacterial peptides YI12 and FK13 used in the experiment came from GL Biochem (Shanghai, China) and were both synthesized by peptide solid-phase synthesis (SPPS).

Techniques: Bacteria, Saline

CD spectrum of YI12 and FK13 under different solutions. Use PBS (10 mM, pH = 7.4), LPS (50 µM), SDS (50 mM), and 50% TFEA. Values are averages of three scans of samples with a peptide concentration of 100 μg/mL.

Journal: Pathogens

Article Title: Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria

doi: 10.3390/pathogens13090797

Figure Lengend Snippet: CD spectrum of YI12 and FK13 under different solutions. Use PBS (10 mM, pH = 7.4), LPS (50 µM), SDS (50 mM), and 50% TFEA. Values are averages of three scans of samples with a peptide concentration of 100 μg/mL.

Article Snippet: The antibacterial peptides YI12 and FK13 used in the experiment came from GL Biochem (Shanghai, China) and were both synthesized by peptide solid-phase synthesis (SPPS).

Techniques: Concentration Assay

Hemolytic activity evaluation of YI12 and FK13 toward mammalian RBCs. Sterilized PBS served as a negative control, and ddH2O served as a positive control.

Journal: Pathogens

Article Title: Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria

doi: 10.3390/pathogens13090797

Figure Lengend Snippet: Hemolytic activity evaluation of YI12 and FK13 toward mammalian RBCs. Sterilized PBS served as a negative control, and ddH2O served as a positive control.

Article Snippet: The antibacterial peptides YI12 and FK13 used in the experiment came from GL Biochem (Shanghai, China) and were both synthesized by peptide solid-phase synthesis (SPPS).

Techniques: Activity Assay, Negative Control, Positive Control

Stability evaluation of antimicrobial  peptides YI12  and FK13 against MRSA T144 and E. coli B2 (MIC, μg/mL).

Journal: Pathogens

Article Title: Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria

doi: 10.3390/pathogens13090797

Figure Lengend Snippet: Stability evaluation of antimicrobial peptides YI12 and FK13 against MRSA T144 and E. coli B2 (MIC, μg/mL).

Article Snippet: The antibacterial peptides YI12 and FK13 used in the experiment came from GL Biochem (Shanghai, China) and were both synthesized by peptide solid-phase synthesis (SPPS).

Techniques: Control

YI12 and FK13 disrupt bacterial membrane permeability. ( A , D ) Outer membrane permeability of E. coli B2 after exposure to YI12 and FK13, respectively, determined using a fluorescent probe N -phenyl-1-naphthylamine (NPN, excitation wavelength 350 nm, emission wavelength 420 nm); ( B , C , E , F ) YI12 and FK13 disrupt bacterial membrane permeability. Detections were performed with the fluorescent probe propidium iodide (PI, excitation 535 nm, emission 615 nm). Statistical analysis was conducted through nonparametric one-way analysis (ns, not significant; ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Journal: Pathogens

Article Title: Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria

doi: 10.3390/pathogens13090797

Figure Lengend Snippet: YI12 and FK13 disrupt bacterial membrane permeability. ( A , D ) Outer membrane permeability of E. coli B2 after exposure to YI12 and FK13, respectively, determined using a fluorescent probe N -phenyl-1-naphthylamine (NPN, excitation wavelength 350 nm, emission wavelength 420 nm); ( B , C , E , F ) YI12 and FK13 disrupt bacterial membrane permeability. Detections were performed with the fluorescent probe propidium iodide (PI, excitation 535 nm, emission 615 nm). Statistical analysis was conducted through nonparametric one-way analysis (ns, not significant; ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Article Snippet: The antibacterial peptides YI12 and FK13 used in the experiment came from GL Biochem (Shanghai, China) and were both synthesized by peptide solid-phase synthesis (SPPS).

Techniques: Membrane, Permeability

Changes in membrane potential of E. coli B2 after exposure to YI12 ( A ) and FK13 ( C ), and MRSA T144 after exposure to YI12 ( B ) and FK13 ( D ). MRSA T144 and E. coli B2 membrane potential was determined by monitoring the fluorescence intensity of 3,3′-dipropylthiodicarbocyanine iodine (DiSC 3 (5)). Excitation wavelength 622 nm, emission wavelength 670 nm.

Journal: Pathogens

Article Title: Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria

doi: 10.3390/pathogens13090797

Figure Lengend Snippet: Changes in membrane potential of E. coli B2 after exposure to YI12 ( A ) and FK13 ( C ), and MRSA T144 after exposure to YI12 ( B ) and FK13 ( D ). MRSA T144 and E. coli B2 membrane potential was determined by monitoring the fluorescence intensity of 3,3′-dipropylthiodicarbocyanine iodine (DiSC 3 (5)). Excitation wavelength 622 nm, emission wavelength 670 nm.

Article Snippet: The antibacterial peptides YI12 and FK13 used in the experiment came from GL Biochem (Shanghai, China) and were both synthesized by peptide solid-phase synthesis (SPPS).

Techniques: Membrane, Fluorescence

YI12 and FK13 trigger the generation of ROS in E. coli B2 and MRSA T144. Generation of ROS in E. coli B2 ( A , D ) and MRSA T144 ( B , E ), determined by 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA, excitation wavelength 488 nm, emission wavelength 525 nm). The addition of the ROS scavenger NAC significantly inhibited the effects of YI12 and FK13 on MRSA T144 and E. coli B2 ( C , F ). Statistical analysis was conducted through nonparametric one-way analysis (ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Journal: Pathogens

Article Title: Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria

doi: 10.3390/pathogens13090797

Figure Lengend Snippet: YI12 and FK13 trigger the generation of ROS in E. coli B2 and MRSA T144. Generation of ROS in E. coli B2 ( A , D ) and MRSA T144 ( B , E ), determined by 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA, excitation wavelength 488 nm, emission wavelength 525 nm). The addition of the ROS scavenger NAC significantly inhibited the effects of YI12 and FK13 on MRSA T144 and E. coli B2 ( C , F ). Statistical analysis was conducted through nonparametric one-way analysis (ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Article Snippet: The antibacterial peptides YI12 and FK13 used in the experiment came from GL Biochem (Shanghai, China) and were both synthesized by peptide solid-phase synthesis (SPPS).

Techniques: